Why the study?
CKD and KFRT are prevalent in AF, but procedural and long-term outcomes after LAAO device implantation in these patients needed analysis.
Does underlying CKD or KFRT increase the risk of procedural complications and long-term adverse events in atrial fibrillation patients undergoing LAAO device implantation?
Does underlying CKD or KFRT increase the risk of procedural complications and long-term adverse events in atrial fibrillation patients undergoing LAAO device implantation?
Answers are grounded in this paper and cite their sources.
In patients undergoing LAAO, underlying CKD and KFRT are associated with increased procedural complications and 1-year mortality, but do not increase the 1-year risk of stroke, suggesting the device remains effective for stroke prevention in this high-risk population.
BACKGROUND: Chronic kidney disease (CKD) and kidney failure with replacement therapy (KFRT) are prevalent in patients with atrial fibrillation (AF). OBJECTIVE: The purpose of this study was to analyze procedural and long-term outcomes in AF patients with underlying CKD and KFRT after left atrial appendage occlusion (LAAO) device implantation. METHODS: Data were extracted from the National Cardiovascular Data Registry LAAO Registry from January 2017 to December 2019 and linked to Centers for Medicare & Medicaid Services billing claims. Patients were stratified into 3 groups: no CKD, CKD, and KFRT. Multivariate analyses were used to assess the associations of CKD and KFRT with procedural and long-term outcomes, respectively. RESULTS: A total of 59,190 patients were enrolled in our study. CKD and KFRT were found to be independently associated with any complication from the procedure (odds ratio [OR] 1.149, 95% confidence interval [CI] 1.058-1.;247 and OR 2.163, 95% CI 1.763-2.652) and in-hospital death (OR 1.603, 95% CI 1.054-2.437; and OR 5.488, 95% CI 2.686-11.213). At 1 year, CKD and KFRT were associated with a higher risk of any major adverse event (hazard ratio [HR] 1.402, 95% CI 1.333-1.474; and HR 2.506, 95% CI 2.236-2.809) and death (HR 1.662, 95% CI 1.553-1.779; and HR 3.422, 95% CI 2.989-3.919), but no difference in the competing risk of stroke (HR 0.972, 95% CI 0.819-1.152; and HR 0.794, 95% CI 0.434-1.451). CONCLUSION: CKD and KFRT were associated with higher rates of procedural complications and 1-year adverse events and death, but no difference in the 1-year rate of stroke.
No takes yet. Share an insight, caveat, or question.
Munir et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: